Results 241 to 250 of about 8,149,283 (401)

New Technology Adoption And Its Impact On Product Development Strategies Among Telecom Professionals In Bengaluru: A Sequential Exploratory Study

Mantu Kumar Tiwari, Lalitha P S
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Enhancing Patient Selection in Sepsis Clinical Trials Design Through an AI Enrichment Strategy: Algorithm Development and Validation.

J Med Internet Res
Yang M, Zhuang J, Hu W, Li J, Wang Y, Zhang Z, Liu C, Chen H.   +7 more
europepmc   +1 more source

PEDAGOGICAL STRATEGIES FOR TEACHING ENGLISH AS A SPECIALIZED LANGUAGE: THE ROLE OF ESP IN PROFESSIONAL DEVELOPMENT

Pulatova Ziyoda Abdumalikovna, Pulatova Ziyoda Abdumalikovna, TSUE, Uzbekistan   +2 more
openalex   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Development of the National Strategy for Quality of Care and Patient Safety for Greece: co-creation process and lessons learnt. [PDF]

Int J Qual Health Care
Fonseca VR, Ivanković D, Vasileiou C, Stridborg M, Triantafyllou C, Myloneros T, Psiakis V, Tsimtsiou Z, Kapaki V, Kaitelidou D, Vildiridi L, Breda J.   +11 more
europepmc   +1 more source

Development Strategy of Islamic Civil Society Organization (CSO) In Indonesia: A Case of Al Jamiyatul Al Wasliyah

Nursapia Harahap, Warjio, Junita Setiana Ginting, Zaki Abdullah, Haykal M. Raihan   +4 more
openalex   +2 more sources

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

Nature reviews. Drug discovery, 2017
D. Schwartz, Y. Kanno, A. Villarino, Michael Ward, M. Gadina, J. O’Shea   +5 more
semanticscholar   +1 more source

IDENTIFICATION OF REALIZATION DIRECTION OF MARKETING STRATEGY OF BALNEOLOGICAL RESORTS DEVELOPMENT [PDF]

, 2013
Dobush, Yu.
core  

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source